Related Experiment Video
Updated: Feb 8, 2026

Evaluating Leaf Responses to Microbial Secondary Metabolites Using A High-Throughput Format
Published on: December 5, 2025
Secondary Stroke Prophylaxis with Clopidogrel Produces Sufficient Antiplatelet Response
Charlotte Lützhøft Rath1, Niklas Rye Jørgensen2, Troels Wienecke3
1Neurovascular Centre, Dept. of Neurology, Zealand University Hospital, Denmark.
Insights
High on-treatment platelet reactivity (HTPR) to clopidogrel was uncommon in Danish ischemic stroke patients. This study found no significant link between clopidogrel HTPR and recurrent ischemic events, suggesting it
Area of Science:
- Cardiology
- Neurology
- Pharmacology
Background:
- Antiplatelet therapy is crucial for preventing secondary ischemic stroke (IS) and transient ischemic attack (TIA).
- A subset of patients on antiplatelet therapy experience recurrent cerebrovascular events.
- High on-treatment platelet reactivity (HTPR) to clopidogrel has been linked to increased recurrent stroke risk.
Purpose of the Study:
- To investigate the association between clopidogrel HTPR and recurrent ischemic events in Danish IS patients.
- To determine if clopidogrel HTPR is a significant risk factor for secondary ischemic events.
Main Methods:
- Prospective observational study design.
- Inclusion of 142 Danish IS patients.
- Assessment of HTPR (platelet reaction units >208) and a 2-year composite endpoint of recurrent stroke, TIA, acute myocardial infarction (AMI), or vascular death.
Main Results:
- Only 2.1% of patients (3 out of 142) exhibited clopidogrel HTPR.
- The incidence of recurrent ischemic events was 10% (14 patients).
- No statistically significant difference in recurrent events was observed between HTPR and non-HTPR groups due to the small number of HTPR patients.
Conclusions:
- Clopidogrel HTPR appears to be infrequent in this Danish IS cohort.
- The study suggests clopidogrel HTPR is not a major driver of recurrent ischemic events in this population.
Background:
Antiplatelet therapy is a cornerstone prevention strategy for secondary ischemic stroke (IS) and transient ischemic attack (TIA). Yet, a proportion of patients who receive antiplatelet therapy experience recurrent ischemic cerebrovascular events. A recent meta-analysis found an increased risk of recurrent stroke in clopidogrel- or aspirin-treated patients with ischemic stroke who had high on-treatment platelet reactivity (HTPR). Few studies have focused specifically on clopidogrel HTPR. Therefore, the aim of this study was to examine the relationship between clopidogrel HTPR and recurrent ischemic events in a population of Danish patients with IS.
Methods:
We performed a prospective observational study to evaluate the relationship between HTPR defined as platelet reaction units >208 and a composite primary endpoint of recurrent stroke, TIA, acute myocardial infarction (AMI), or vascular death over a 2-year follow-up period.
Results:
A total of 142 patients were included in the final statistical analysis, but only 3 patients (2.1%) demonstrated clopidogrel HTPR. The median time of on-treatment platelet testing was 75 days. Recurrent IS, TIA, AMI, or vascular death occurred in 14 patients (10%). Of these, 1 new ischemic event (AMI) occurred in a HTPR patient. There was no difference in the frequency of new ischemic events between the HTPR and non-HTPR groups (P = .27); moreover, the number of patients with HTPR was too small for statistical analysis.
Conclusions:
Clopidogrel HTPR does not seem to be a major contributor to recurrent ischemic events in Danish ischemic stroke patients.
Related Concept Videos
Primary and Secondary Growth in Roots and Shoots
Secondary Active Transport
Secondary Active Transport
Secondary Healthcare System
Secondary Distribution
In residential areas, 120/240 V single-phase, three-wire service is commonly used for lighting, outlets, and large appliances. Urban areas with high-density loads...
Secondary Lymphoid Organs
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...

